Cargando…
The new era of atrial fibrillation treated by direct oral anticoagulants and catheter ablation—Comment on the “HAF‐NET Registry”
Autores principales: | Yoshiga, Yasuhiro, Shimizu, Akihiko, Yano, Masafumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6786978/ https://www.ncbi.nlm.nih.gov/pubmed/31624508 http://dx.doi.org/10.1002/joa3.12242 |
Ejemplares similares
-
One‐year clinical outcomes of anticoagulation therapy among Japanese patients with atrial fibrillation: The Hyogo AF Network (HAF‐NET) Registry
por: Hyogo, Kiyohiro, et al.
Publicado: (2019) -
Association between the atrial tachyarrhythmia recurrence period and long-term major adverse clinical events following catheter ablation for atrial fibrillation
por: Ishiguchi, Hironori, et al.
Publicado: (2023) -
Report of periprocedural oral anticoagulants in catheter ablation for atrial fibrillation: The Japanese Catheter Ablation Registry of Atrial Fibrillation (J-CARAF)
por: Murakawa, Yuji, et al.
Publicado: (2017) -
Delayed cardiac tamponade in catheter ablation for paroxysmal atrial fibrillation induced by a subacute hemorrhage
por: Ishiguchi, Hironori, et al.
Publicado: (2020) -
Long‐term events following catheter‐ablation for atrial fibrillation in heart failure with preserved ejection fraction
por: Ishiguchi, Hironori, et al.
Publicado: (2022)